Stock Events

Stock Events

Bristol-Myers Squibb 

$0.118500
8844
+$0.03+28.8% Thursday 19:57

Statistics

Day High
0.1185
Day Low
0.0921
52W High
0.1185
52W Low
0.0921
Volume
25,380
Avg. Volume
-
Mkt Cap
241.99M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

30JulExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Next
1.09
1.33
1.56
1.8
Expected EPS
1.605748
Actual EPS
N/A

Financials

14.64%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
96.39BRevenue
14.11BNet Income

Analyst Ratings

65.22Average Price Target
The highest estimate is 75.00.
From 9 ratings within the last 6 months. This is not an investment recommendation.
Buy
56%
Hold
44%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CELG-RI. It's not an investment recommendation.
Realty Income
2355
O
Coca-Cola
1972
KO
Apple
1967
AAPL
Johnson & Johnson
1939
JNJ

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap138.61B
Pfizer competes directly in various therapeutic areas including oncology, immunology, and cardiovascular diseases.
Merck
MRK
Mkt Cap319.99B
Merck & Co. is a key competitor in the pharmaceutical industry, especially in the oncology segment with its blockbuster cancer drug Keytruda.
Johnson & Johnson
JNJ
Mkt Cap633.19B
Johnson & Johnson competes across multiple segments including pharmaceuticals, with a strong presence in immunology and oncology.
Abbvie
ABBV
Mkt Cap461.26B
AbbVie competes in areas like immunology and oncology, directly challenging Bristol-Myers Squibb's product lineup.
GSK
GSK
Mkt Cap107.47B
GlaxoSmithKline competes in the pharmaceutical and healthcare sector, with a focus on respiratory diseases, HIV, and vaccines.
Novartis
NVS
Mkt Cap305.1B
Novartis is a global healthcare company that competes in various therapeutic areas including cardiovascular, oncology, and immunology.
AMGEN
AMGN
Mkt Cap201.93B
Amgen competes in the biopharmaceutical sector, focusing on human therapeutics, including treatments for cancer and cardiovascular disease.
Sanofi
SNY
Mkt Cap103.32B
Sanofi competes in the global pharmaceutical market, with a focus on diabetes, oncology, and rare diseases.
Roche
RHHBY
Mkt Cap341.62B
Roche Holding AG competes in the pharmaceutical and diagnostics sectors, with a strong emphasis on oncology and immunology.
Astrazeneca
AZN
Mkt Cap302.65B
AstraZeneca is a global, science-led biopharmaceutical business that competes in core areas of healthcare, including oncology, cardiovascular, renal, and metabolism.

About

Bristol Myers Squibb Company (BMS) operates as a biopharmaceutical enterprise, managing the entire lifecycle of its therapeutic products, from initial discovery and development to manufacturing, marketing, and distribution. Its diverse portfolio includes conventional small molecule drugs, advanced biologics (which are derived from biological processes), and specialized chimeric antigen receptor (CAR-T) cell therapies. The company was established in August 1933 and maintains its corporate headquarters in Princeton, New Jersey.
Show more...
CEO
Employees
34100
Country
United States
ISIN
US1101221406

Listings

STU
DE
BRM.STU
XETRA
DE
BRM.XETRA
BA
AR
BMY.BA
SA
BR
BMYB34.SA

0 Comments

Share your thoughts

FAQ

What is Bristol-Myers Squibb stock price today?▼
The current price of CELG-RI is $0.12 USD — it has increased by +28.8% in the past 24 hours. Watch Bristol-Myers Squibb stock price performance more closely on the chart.
What is Bristol-Myers Squibb stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNYS exchange Bristol-Myers Squibb stocks are traded under the ticker CELG-RI.
What is Bristol-Myers Squibb market cap?▼
Today Bristol-Myers Squibb has the market capitalization of 241.99M
When is the next Bristol-Myers Squibb earnings date?▼
Bristol-Myers Squibb is going to release the next earnings report on July 30, 2026.
What were Bristol-Myers Squibb earnings last quarter?▼
CELG-RI earnings for the last quarter are 1.58 USD per share, whereas the estimation was 1.42 USD resulting in a +10.99% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Bristol-Myers Squibb revenue for the last year?▼
Bristol-Myers Squibb revenue for the last year amounts to 96.39B USD.
What is Bristol-Myers Squibb net income for the last year?▼
CELG-RI net income for the last year is 14.11B USD.
How many employees does Bristol-Myers Squibb have?▼
As of July 10, 2026, the company has 34,100 employees.
In which sector is Bristol-Myers Squibb located?▼
Bristol-Myers Squibb operates in the Other sector.
When did Bristol-Myers Squibb complete a stock split?▼
Bristol-Myers Squibb has not had any recent stock splits.